RNXT RenovoRx Inc
Price (delayed)
$1
Market cap
$36.55M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.4
Enterprise value
$29.6M
Highlights
The EPS has soared by 60% YoY and by 30% from the previous quarter
The net income has increased by 14% year-on-year and by 3.8% since the previous quarter
The company's equity fell by 37% QoQ
The quick ratio has contracted by 30% from the previous quarter
Key stats
What are the main financial stats of RNXT
Market
Valuations
Earnings
Shares outstanding
36.55M
Market cap
$36.55M
Enterprise value
$29.6M
Price to earnings (P/E)
N/A
Price to book (P/B)
5.36
Price to sales (P/S)
517.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
688.48
Revenue
$43,000
Gross profit
$43,000
Operating income
-$10.97M
Net income
-$8.81M
EBIT
-$9.2M
EBITDA
-$9.19M
Free cash flow
-$9.14M
Per share
Balance sheet
Liquidity
EPS
-$0.4
EPS diluted
-$0.4
Free cash flow per share
-$0.41
Book value per share
$0.19
Revenue per share
$0
TBVPS
$0.36
Total assets
$8.12M
Total liabilities
$3.64M
Debt
$212,000
Equity
$4.48M
Working capital
$5.92M
Debt to equity
0.05
Current ratio
4.1
Quick ratio
3.77
Net debt/EBITDA
0.76
Margins
Efficiency
Dividend
EBITDA margin
-21,374.4%
Gross margin
100%
Net margin
-20,497.7%
Operating margin
-25,511.6%
Return on assets
-100.9%
Return on equity
-156.1%
Return on invested capital
N/A
Return on capital employed
-148.1%
Return on sales
-21,390.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RNXT stock price
How has the RenovoRx stock price performed over time
Intraday
4.17%
1 week
-1.96%
1 month
0.01%
1 year
-19.35%
YTD
-22.48%
QTD
1.01%
Financial performance
How have RenovoRx's revenue and profit performed over time
Revenue
$43,000
Gross profit
$43,000
Operating income
-$10.97M
Net income
-$8.81M
Gross margin
100%
Net margin
-20,497.7%
The net income has increased by 14% year-on-year and by 3.8% since the previous quarter
The operating income is down by 8% QoQ but it is up by 3.7% YoY
Growth
What is RenovoRx's growth rate over time
Valuation
What is RenovoRx stock price valuation
P/E
N/A
P/B
5.36
P/S
517.93
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
688.48
The EPS has soared by 60% YoY and by 30% from the previous quarter
The company's equity fell by 37% QoQ
The P/B is 4.6% below the last 4 quarters average of 5.4
Efficiency
How efficient is RenovoRx business performance
RNXT's ROE has soared by 94% YoY and by 36% QoQ
RNXT's ROA has soared by 61% YoY and by 22% from the previous quarter
Dividends
What is RNXT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RNXT.
Financial health
How did RenovoRx financials performed over time
RNXT's total assets is 123% greater than its total liabilities
The quick ratio has contracted by 30% from the previous quarter
The current ratio has declined by 28% since the previous quarter
RenovoRx's debt is 95% lower than its equity
The company's equity fell by 37% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.